Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listmethyl(2,3,3-trimethyltrinorbornan-2-yl)amine

methyl(2,3,3-trimethyltrinorbornan-2-yl)amine

methyl(2,3,3-trimethyltrinorbornan-2-yl)amine Structural

What is methyl(2,3,3-trimethyltrinorbornan-2-yl)amine?

Absorption

Mecamylamine is almost completely absorbed from the gastrointestinal tract

Originator

Inversine ,MSD ,US ,1956

The Uses of methyl(2,3,3-trimethyltrinorbornan-2-yl)amine

Antihypertensive.

Background

A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Indications

For the treatment of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension

Definition

ChEBI: Mecamylamine is a primary aliphatic amine.

Manufacturing Process

Preparation of 2-(N-Formylamino)Isocamphane: Into a 5-liter 3-necked round bottom flask equipped with stirrer, dropping funnel and thermometer, was added 325 ml of glacial acetic acid. Then, portionwise, a total of 133 g of sodium cyanide (granular, 2.6 mols) was added with stirring while holding the temperature at 15°C. To the thick white slurry was added dropwise a previously prepared cold mixture of 325 ml glacial acetic acid and 360 ml concentrated sulfuric acid.
After addition of a few milliliters at 15°C, the thick slurry thins slowly and the remainder of the sulfuric-glacial acetic acid mixture was added at 0° to 2°C. A total of about 2 hours was required for the addition. After addition, stirring was continued for 15 minutes, Then dropwise, over an hour, a solution of 178 g (1.3 mold of dl-camphene in 50 ml of glacial acetic acid was added while keeping the temperature at about 0°C (±3°C).
Stirring was continued for two hours at 0°C during which time a slight pinkish-yellow color developed in the reaction mixture. The cooling bath was removed and the temperature allowed to rise to 15° to 20°C in about 2 to 3 hours. The ice bath was then re placed and while holding the temperature at about 20°C, the mixture was gradually diluted with 3 liters of water while stirring vigorously. After an hour or two of good agitation at room temperature, the oily product was extracted with 2 x 500 ml and 1 x 200 ml of chloroform and the combined extracts washed with 2 x 500 ml of water. The chloroform extract was then rendered neutral by stirring with 500 ml water and gradually adding solid sodium bicarbonate to the mixture until the aqueous phase had a pH of about 7; required, approximately 88 g of NaHCO3.
After separation the chloroform layer was washed with 2 x 500 ml water, dried over calcium chloride, and after filtration the solvent was removed in vacuo on the steam bath. A solid somewhat sticky residue of 231.2 g was obtained. After removal of last traces of chloroform by repeated swishing with petroleum ether, the cake was finally refluxed with about 500 ml petroleum ether (BP 30° to 60°C) until a thick crystalline slurry was obtained. After refrigeration for a day, the white crystalline mass was filtered by suction, washed with petroleum ether (2 x 125 ml), then n-heptane (2 x 125 ml) and again with petroleum ether (2 x 125 ml). After air drying at room temperature to constant weight, 180.6 g of the dl-2-(N-formylamino)isocamphane melting at 160° to 165°C was obtained.
The combined petroleum ether and n-heptane washes were concentrated under diminished pressure and the residual oil dissolved in a minimum amount of hot petroleum ether (about 75 ml). The resulting solution was placed in the refrigerator for two days. The precipitated dl-2-(N-formylamino) isocamphane was then recovered by filtration and washed with petroleum ether and n-heptane as described above. Obtained, 12.6 g of product having a MP of 158° to 164°C.
The dl-2-(N-formylamino)isocamphane (193 g) was dissolved in 1.9 liters nheptane by heating on a steam bath, After clarifying the solution by filtration, the clear filtrate was allowed to stand at room temperature until crystallization was complete. The crystalline product is filtered by suction, washed with a little cold n-heptane and air dried. The dl-2-(N-formylamino)isocamphane melted at 169° to 174°C.
Preparation of 2-(N-Methylamino)Isocamphane: To 4.23 liters of anhydrous ether in a 12-liter 3-necked flask fitted with a stirrer, reflux condenser and dropping funnel was quickly added 78 g (2.05 mols) of lithium aluminum hydride. The mixture was gently refluxed with stirring until all hydride had dissolved which required several hours.
A solution of 168 g (0.92 mol) of dl-2-(N-formylamino)isocamphane, prepared as described above, in 1.81 liters of anhydrous ether was then added during a period of about one hour with stirring. After addition, the mixture was refluxed for about 6 hours after which it was cooled slightly and 347 ml of water added with stirring, hydrogen gas being evolved during the addition, Stirring was continued until the precipitate changed to a powder, which was filtered by suction and washed with ether (a total of about 2 liters).
The combined filtrate and washes were concentrated to 1.6 liters and the concentrate containing the dl-2-(N-methylamino)isocamphane washed once with about 350 cc water, and then dried over anhydrous sodium sulfate. The dried ether concentrate was then cooled in an ice bath and with stirring a cold saturated ethereal-hydrogen chloride solution was added slowly until acid to Congo red; required, about 440 ml anhydrous ether saturated (at 0°C) with HCl gas, After precipitation was complete, the white crystalline dl-2-(Nmethylamino)isocamphane hydrochloride was filtered, and washed with anhydrous ether (about 1 liter) until the washes were neutral. The dl-2-(Nmethylamino)isocamphane hydrochloride was air dried at room temperature. Obtained, 156.5 g of product melting with decomposition at 249°C.

Therapeutic Function

Antihypertensive

Pharmacokinetics

Mecamylamine is a potent, oral antihypertensive agent and ganglion blocker, and is a secondary amine. Mecamylamine is indicated for the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension. Mecamylamine reduces blood pressure in both normotensive and hypertensive individuals. A small oral dosage often produces a smooth and predictable reduction of blood pressure. Although this antihypertensive effect is predominantly orthostatic, the supine blood pressure is also significantly reduced. Mecamylamine crosses the blood-brain and placental barriers.

Metabolism

Not Available

Properties of methyl(2,3,3-trimethyltrinorbornan-2-yl)amine

Melting point: 245-256℃
Boiling point: 189℃
Density  0.91
refractive index  1.4875
Flash point: 58℃
EPA Substance Registry System Bicyclo[2.2.1]heptan-2-amine, N,2,3,3-tetramethyl- (60-40-2)

Safety information for methyl(2,3,3-trimethyltrinorbornan-2-yl)amine

Computed Descriptors for methyl(2,3,3-trimethyltrinorbornan-2-yl)amine

Related products of tetrahydrofuran

You may like

Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.